Eliem Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Eliem Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q2 2024.
  • Eliem Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $512K, a 34.1% decline year-over-year.
  • Eliem Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $2.84M, a 80.6% decline year-over-year.
  • Eliem Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $12.8M, a 83.2% increase from 2022.
  • Eliem Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.99M, a 87.1% increase from 2021.
  • Eliem Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.74M, a 429% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.84M $512K -$265K -34.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $3.1M $465K -$9.71M -95.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $12.8M $1.2M -$693K -36.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $13.5M $656K -$1.13M -63.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $14.6M $777K -$995K -56.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $15.6M $10.2M +$8.63M +560% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $6.99M $1.9M +$741K +64.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $6.25M $1.78M +$547K +44.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $5.7M $1.77M +$722K +68.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $4.98M $1.54M +$1.24M +419% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $3.74M $1.15M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 $1.24M +$1.19M +2422% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $1.05M +$999K +1959% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $297K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 $49K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $51K Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.